Mustang Bio Statistics
Total Valuation
Mustang Bio has a market cap or net worth of $5.66 million. The enterprise value is -$10.60 million.
Important Dates
The next estimated earnings date is Monday, May 18, 2026, after market close.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Mustang Bio has 7.58 million shares outstanding. The number of shares has increased by 705.02% in one year.
| Current Share Class | 6.73M |
| Shares Outstanding | 7.58M |
| Shares Change (YoY) | +705.02% |
| Shares Change (QoQ) | +3.68% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 21.00% |
| Float | 5.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.12
| Current Ratio | 2.12 |
| Quick Ratio | 2.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -44.62% and return on invested capital (ROIC) is -33.15%.
| Return on Equity (ROE) | -44.62% |
| Return on Assets (ROA) | -12.85% |
| Return on Invested Capital (ROIC) | -33.15% |
| Return on Capital Employed (ROCE) | -37.01% |
| Weighted Average Cost of Capital (WACC) | 15.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$680,750 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.35% in the last 52 weeks. The beta is 2.11, so Mustang Bio's price volatility has been higher than the market average.
| Beta (5Y) | 2.11 |
| 52-Week Price Change | -33.35% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 45.08 |
| Average Volume (20 Days) | 40,254 |
Short Selling Information
The latest short interest is 101,076, so 1.33% of the outstanding shares have been sold short.
| Short Interest | 101,076 |
| Short Previous Month | 125,433 |
| Short % of Shares Out | 1.33% |
| Short % of Float | 1.89% |
| Short Ratio (days to cover) | 2.77 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.24M |
| Pretax Income | -2.72M |
| Net Income | -2.72M |
| EBITDA | -3.23M |
| EBIT | -3.24M |
| Earnings Per Share (EPS) | -$0.46 |
Full Income StatementBalance Sheet
The company has $16.26 million in cash and n/a in debt, with a net cash position of $16.26 million or $2.15 per share.
| Cash & Cash Equivalents | 16.26M |
| Total Debt | n/a |
| Net Cash | 16.26M |
| Net Cash Per Share | $2.15 |
| Equity (Book Value) | 8.60M |
| Book Value Per Share | 1.13 |
| Working Capital | 8.75M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.88M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 34,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.26M |
| FCF Per Share | -$0.69 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
